z-logo
open-access-imgOpen Access
Activation of caspase-activated deoxyribonuclease and neuroprotective effect of caspase-3 inhibitor after focal cerebral ischemia-reperfusion injury
Author(s) -
Ying Zhang
Publication year - 2013
Publication title -
african journal of pharmacy and pharmacology
Language(s) - English
Resource type - Journals
ISSN - 1996-0816
DOI - 10.5897/ajpp12.691
Subject(s) - neuroprotection , apoptosis , ischemia , dna fragmentation , caspase 3 , pharmacology , caspase , brain ischemia , biology , anesthesia , medicine , biochemistry , programmed cell death
Caspase-3 is a key enzyme to execute apoptosis and may be cause internucleosomal DNA fragmentation in ischemic neurons. However, whether caspase-3 inhibitor can directly inhibit caspase-3–dependent deoxyribonuclease activity and prevent neuronal apoptosis following cerebral ischemic is unknown. In this study, we detected the caspase-3 and CAD protein, as well as the frequencies of neuronal apoptosis in both model control group (DMSO injection) and treatment group (Ac-DEVD-CHO injection) after focal cerebral ischemia-reperfusion in rats. Our data showed that caspase-3 and CAD protein were detectable, and apoptotic-like neuronal death occurred following cerebral ischemic in both groups. However, these results obtained were inhibited by Ac-DEVD-CHO in treatment group as compared with model control group. Taken together, these data further support that the pathway of caspase-3–dependent CAD activity and neuronal apoptosis is an important mechanism in ischemic neuronal injury, and Ac-DEVD-CHO has the neuroprotective effect to a certain degree.   Key words: Caspase-3, caspase-activated deoxyribonuclease, Ac-DEVD-CHO, apoptosis, cerebral ischemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom